Molecular Mechanism of Localization of the Mutant Ornithine Transcarbamylase to Mitochondrial Compartment
Molecular Mechanism of Localization of the Mutant Ornithine Transcarbamylase to Mitochondrial Compartment
批准号:
09670854
负责人:
YOSHINO Makoto
金额:
$1.79万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1999
中文摘要
1)野生型和突变型鸟氨酸转氨酶(OTC)向线粒体转运的研究从野生型和突变型OTC基因中提取OTC信使RNA。用S35进行体外翻译,并将标记的OTC加入分离的大鼠肝线粒体。孵育后,将标记掺入Sephadex柱上分离的不同分子大小的蛋白质组分中。就洗脱体积和蛋白质组分中的放射性而言,标记的加入是不能重复性的,因此有必要进一步改进实验条件。2)对有OTC缺乏症风险的新生儿进行产前监测。在一名死于高氨血症危象的男性新生儿中发现了OTC基因I261T突变。在连续怀孕期间进行了产前诊断,结果显示胎儿是女性,并且没有携带突变的等位基因。家系中的基因追踪显示,该突变是新近发生在母亲身上的。3)男性迟发性OTC缺乏症患者的预后因素分析。为探讨影响患者生存预后的因素,对10例男性患者进行了回顾性分析,均未发现OTC基因R40H突变和Y55D突变。首次比较两组共32个因素,进一步进行简单回归分析,发现发病年龄、血氨峰值、血浆8种氨基酸浓度是有意义的预测因素。
英文摘要
1) Research on the transport of wild-type and mutant ornithine transcarbamylase (OTC) into mitochondrial compartmentOTC messenger RNA was isolated from cells transfected with either the wild-type or the R40H OTC cDNA. The mRNA was in vitro-translated with S35, and the labeled OTC was added to isolated rat liver mitochondria. After incubation, incorporation of the label into the protein fractions of various molecular sizes separated on a sephadex column were measured. The incorporation of the label was not reproducible in terms of elution volume and radioactivity in the protein fraction, and further refinements of the experimental conditions were necessary.2) Prenatal monitoring of a pregnancy at risk for OTC deficiency with neonatal onsetThe I261T mutation in the OTC gene was identified in a male neonate who died from hyperammonemic crisis. prenatal diagnosis was done in the successive pregnancy, which revealed that the fetus was female, and that it did not carry the mutant allele. Gene tracking in the family revealed that the mutation was freshly occurred in the mother.3) Analysis of prognostic factors in male patients with late-onset OTC deficiencyPrognosis of life has been generally poor in male patients with the late-onset OTC to deficiency. To elucidate factors that are concerned with prognosis of life, retrospective analysis was done in ten male patients with the disease, none of whom carried the R40H mutation and the other, the Y55D mutation in the OTC gene. A total of 32 factors were first compared in the two groups were further subjected to simple regression analysis, which revealed that age at onset, peak plasma ammonia concentration, concentrations in plasma of eight amino acids were determined to be significant predictors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
芳野 信: "高アンモニア血症"小児内科. 31. 605-608 (1999)
Shin Yoshino:“高氨血症”小儿内科。 31. 605-608 (1999)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
芳野 信、西依 淳他: "男子遅発型ornithine transcarbamylase(OTC) 欠損症の臨床像と予後因子"日本先天代謝異常学会雑誌、in press.
Shin Yoshino、Jun Nishii 等人:“男孩迟发性鸟氨酸转氨甲酰酶 (OTC) 缺乏症的临床特征和预后因素”,《日本遗传代谢紊乱学会杂志》,出版中。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
芳野 信: "先天性高アンモニア血症の臨床と分子病理"久留米医学会雑誌. 60. 241-249 (1997)
Shin Yoshino:“先天性高氨血症的临床和分子病理学”久留米医学会杂志 60. 241-249 (1997)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Nishiyori A,et al.: "Y55D mutation in ornithine transcarbamylase associated with late-onset hyperammonemia in a male." Hum Mutat. S1. S131-S133 (1998)
Nishiyori A 等人:“鸟氨酸转氨甲酰酶 Y55D 突变与男性迟发性高氨血症相关。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Koga Y,et al.: "Maple syrup urine disease : nutritional management by intravenous hyperalim entation and uneventful course after surgicak repair of dislocation of the hip." J Inher Metab Dis. 21. 177-178 (1998)
Koga Y 等人:“枫糖浆尿病:通过静脉高营养进行营养管理以及髋关节脱位手术修复后平稳的过程。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 10 条
A study on Presymptomatic recognition and prevention of late-onset ornithine transcarbamylase deficiency in male
-
批准号:15591148
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2003
-
负责人:YOSHINO Makoto
-
依托单位:
A Study on Molecular Epidemiology and Prevention of Onset of Late-onset Ornithine Transcarbamylase Deficiency in Male Patients
-
批准号:12670796
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.47万
-
财政年份:2000
-
负责人:YOSHINO Makoto
-
依托单位:
Molecular Mechanism of Late Onset Type of Ornithine Transcarbamylase Deficiency in Males
-
批准号:06670843
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.09万
-
财政年份:1994
-
负责人:YOSHINO Makoto
-
依托单位:
A study on the mutations at the phynylalanine hydroxylase gene among the Japanese population
-
批准号:02670467
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1990
-
负责人:YOSHINO Makoto
-
依托单位:
国内基金
海外基金
登录
查看更多内容
DJ-1与Calnexin互作调控线粒体—内质网联络区参与帕金森病病理机制的研究
-
批准号:82371414
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:黄沛
-
依托单位:
MitoNEET通过调控线粒体形态和功能减轻肾脏缺血再灌注损伤的作用及机制研究
-
批准号:32100537
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:齐元博
-
依托单位:
线粒体炫和活性氧信号调控细胞能量代谢平衡的机制研究
-
批准号:92157105
-
项目类别:重大研究计划
-
资助金额:54.0万元
-
批准年份:2021
-
负责人:王显花
-
依托单位:
基于超分辨活细胞成像的MDVs形成过程及分子机制的研究
-
批准号:32000480
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:郭玉婷
-
依托单位:
线粒体互作网络调控线粒体稳态并参与乳腺癌发生发展的机制研究
-
批准号:92054108
-
项目类别:重大研究计划
-
资助金额:87.0万元
-
批准年份:2020
-
负责人:卫涛涛
-
依托单位:
脂滴与线粒体的互作在巨噬细胞和动脉粥样硬化中的作用及机制研究
-
批准号:32000482
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:魏园园
-
依托单位:
线虫线粒体组织特异性分离及其蛋白组学分析
-
批准号:31900498
-
项目类别:青年科学基金项目
-
资助金额:26.0万元
-
批准年份:2019
-
负责人:任学聪
-
依托单位:
重编程早期线粒体通透性转换孔开放对PHF8的调控及机制
-
批准号:31970709
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:应仲富
-
依托单位:
PET117蛋白与细胞核-线粒体基因表达协调
-
批准号:31970654
-
项目类别:面上项目
-
资助金额:52.0万元
-
批准年份:2019
-
负责人:丁健
-
依托单位:
线粒体beta-桶膜蛋白调控生物大分子跨膜转运的分子机制
-
批准号:31972886
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:邱健
-
依托单位: